<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre=", This article is being made freely available through PubMed" exact="Central" post="as part of the COVID-19 public health emergency response."/>
 <result pre="recently proposed conceptual models that estimate the spread of this" exact="disease" post="based on the basic reproductive number for better prevention"/>
 <result pre="India List of Abbreviations ACE2 Angiotensin Converting Enzyme II ARDS" exact="Acute" post="Respiratory Distress Syndrome COVIDâ€�19 Coronavirus Disease 2019 ODE Ordinary"/>
 <result pre="List of Abbreviations ACE2 Angiotensin Converting Enzyme II ARDS Acute" exact="Respiratory" post="Distress Syndrome COVIDâ€�19 Coronavirus Disease 2019 ODE Ordinary Differential"/>
 <result pre="Abbreviations ACE2 Angiotensin Converting Enzyme II ARDS Acute Respiratory Distress" exact="Syndrome" post="COVIDâ€�19 Coronavirus Disease 2019 ODE Ordinary Differential Equation PCR"/>
 <result pre="Converting Enzyme II ARDS Acute Respiratory Distress Syndrome COVIDâ€�19 Coronavirus" exact="Disease" post="2019 ODE Ordinary Differential Equation PCR Polymerase Chain Reaction"/>
 <result pre="virus as SARSâ€�CoVâ€�2,1 because of the previously identified variantâ€� severe" exact="acute" post="respiratory syndrome coronavirus (SARSâ€�CoV). The clinical illness it causes"/>
 <result pre="as SARSâ€�CoVâ€�2,1 because of the previously identified variantâ€� severe acute" exact="respiratory" post="syndrome coronavirus (SARSâ€�CoV). The clinical illness it causes is"/>
 <result pre="SARSâ€�CoVâ€�2,1 because of the previously identified variantâ€� severe acute respiratory" exact="syndrome" post="coronavirus (SARSâ€�CoV). The clinical illness it causes is termed"/>
 <result pre="(SARSâ€�CoV). The clinical illness it causes is termed as coronavirus" exact="disease" post="2019 (COVIDâ€�19).2 While several other human coronaviruses such as"/>
 <result pre="coronaviruses such as HCoVâ€�NL63, HCoVâ€�229E, HCoVâ€�OC43, and HCoVâ€�HKU1 cause mild" exact="respiratory" post="disease, others like the zoonotic Middle East respiratory syndrome"/>
 <result pre="cause mild respiratory disease, others like the zoonotic Middle East" exact="respiratory" post="syndrome coronavirus (MERSâ€�CoV) and SARSâ€�CoV tend to have a"/>
 <result pre="mild respiratory disease, others like the zoonotic Middle East respiratory" exact="syndrome" post="coronavirus (MERSâ€�CoV) and SARSâ€�CoV tend to have a higher"/>
 <result pre="higher fatality rate6 (summarized in Table 1). TABLE 1 Major" exact="respiratory" post="outbreaks in last century Outbreak Most affected age groups"/>
 <result pre="All age groups Southern China 1â€�4 million 0.1%â€�0.2% 1968â€�1969 Serious" exact="acute" post="respiratory syndrome (SARS) Middleâ€�aged adults (45â€�65) China 774 &amp;lt;10%"/>
 <result pre="age groups Southern China 1â€�4 million 0.1%â€�0.2% 1968â€�1969 Serious acute" exact="respiratory" post="syndrome (SARS) Middleâ€�aged adults (45â€�65) China 774 &amp;lt;10% 2002â€�2003"/>
 <result pre="groups Southern China 1â€�4 million 0.1%â€�0.2% 1968â€�1969 Serious acute respiratory" exact="syndrome" post="(SARS) Middleâ€�aged adults (45â€�65) China 774 &amp;lt;10% 2002â€�2003 Swine"/>
 <result pre="adults and pregnant women Mexico 18â€‰000 &amp;lt;0.025% 2009â€�2010 Middle east" exact="respiratory" post="syndrome (MERS) Elderly (60+) Middle East 861 &amp;gt;30% 2012"/>
 <result pre="and pregnant women Mexico 18â€‰000 &amp;lt;0.025% 2009â€�2010 Middle east respiratory" exact="syndrome" post="(MERS) Elderly (60+) Middle East 861 &amp;gt;30% 2012 COVIDâ€�19"/>
 <result pre="140â€‰000 cases in US, and over 100â€‰000 in Italy. The" exact="total" post="global number of COVIDâ€�19 cases has surpassed 700â€‰000, infecting"/>
 <result pre="emergency on January 30, 2020.7 Very recently, inertia in combating" exact="viral" post="spread helped increase the number of cases outside China"/>
 <result pre="Alpha: Originate from mammals, particularly bats, cause asymptomatic or mildly" exact="symptomatic" post="infections Beta: Originate from mammals, particularly bats, can cause"/>
 <result pre="Originate from mammals, particularly bats, cause asymptomatic or mildly symptomatic" exact="infections" post="Beta: Originate from mammals, particularly bats, can cause severe"/>
 <result pre="infections Beta: Originate from mammals, particularly bats, can cause severe" exact="disease" post="and fatalities. SARSâ€�CoVâ€�2 belongs to the betaâ€�coronaviruses and is"/>
 <result pre="96% identical to a bat coronavirus at the wholeâ€�genome level.11" exact="Gamma" post="and delta: Originate from pigs and birds The genome"/>
 <result pre="presumably in the seafood market in Wuhan, China. However, potential" exact="intermediate" post="hosts remain to be identified and the precise route"/>
 <result pre="for SARSâ€�CoVâ€�2 is angiotensinâ€�converting enzyme 2 (ACE2),13 expressed normally on" exact="type I" post="and II alveolar epithelial cells of human lung and"/>
 <result pre="2 (ACE2),13 expressed normally on type I and II alveolar" exact="epithelial" post="cells of human lung and intestinal epithelia.14 Eightyâ€�three percent"/>
 <result pre="cells of human lung and intestinal epithelia.14 Eightyâ€�three percent of" exact="Type II" post="alveolar epithelial cells express ACE2 receptor. The binding of"/>
 <result pre="lung and intestinal epithelia.14 Eightyâ€�three percent of Type II alveolar" exact="epithelial" post="cells express ACE2 receptor. The binding of SARSâ€�CoVâ€�2019 to"/>
 <result pre="alveolar cell damage. This in turn triggers a cascade of" exact="systemic" post="reactions. It has also been suggested that the receptorâ€�binding"/>
 <result pre="compared to series of recent cases.16, 17 2.3 Pathophysiology The" exact="primary" post="pathology of COVIDâ€�19 is ARDS (Acute Respiratory Distress Syndrome),"/>
 <result pre="2.3 Pathophysiology The primary pathology of COVIDâ€�19 is ARDS (Acute" exact="Respiratory" post="Distress Syndrome), characterized by diffuse damage of alveolar cells"/>
 <result pre="of COVIDâ€�19 is ARDS (Acute Respiratory Distress Syndrome), characterized by" exact="diffuse" post="damage of alveolar cells and hyaline membranes. Direct invasion"/>
 <result pre="with an exuberant â€œcytokine release stormâ€� (that shows characteristics of" exact="hemophagocytic lymphohistiocytosis" post="or bacterial sepsis). The condition may show clinical markers"/>
 <result pre="â€œcytokine release stormâ€� (that shows characteristics of hemophagocytic lymphohistiocytosis or" exact="bacterial" post="sepsis). The condition may show clinical markers of enhanced"/>
 <result pre="levels of ferritin and Câ€�reactive protein that may correspond with" exact="disease" post="mortality and severity.19 2.4 Stages of illness The patients"/>
 <result pre="the virus resulting in fairly mild symptoms due to direct" exact="viral" post="cytopathic effect. Adaptive immunity stage â€� The innate immune"/>
 <result pre="describe asymptomatic infections, particularly among young children.21 SARSâ€�CoVâ€�2019 may cause" exact="lower" post="respiratory symptoms, upper respiratory symptoms, constitutional symptoms, and, less"/>
 <result pre="asymptomatic infections, particularly among young children.21 SARSâ€�CoVâ€�2019 may cause lower" exact="respiratory" post="symptoms, upper respiratory symptoms, constitutional symptoms, and, less commonly,"/>
 <result pre="particularly among young children.21 SARSâ€�CoVâ€�2019 may cause lower respiratory symptoms," exact="upper" post="respiratory symptoms, constitutional symptoms, and, less commonly, gastrointestinal symptoms."/>
 <result pre="among young children.21 SARSâ€�CoVâ€�2019 may cause lower respiratory symptoms, upper" exact="respiratory" post="symptoms, constitutional symptoms, and, less commonly, gastrointestinal symptoms. Most"/>
 <result pre="constitutional symptoms, and, less commonly, gastrointestinal symptoms. Most patients show" exact="lower" post="respiratory symptoms and constitutional symptoms (eg, cough and fever)."/>
 <result pre="symptoms, and, less commonly, gastrointestinal symptoms. Most patients show lower" exact="respiratory" post="symptoms and constitutional symptoms (eg, cough and fever). The"/>
 <result pre="relate to different strains of virus or different levels of" exact="disease" post="severity between several cohorts. Regardless of the frequency, absence"/>
 <result pre="of disease severity between several cohorts. Regardless of the frequency," exact="absence of" post="fever in a patient does not exclude COVIDâ€�19. About"/>
 <result pre="COVIDâ€�19. About 80% of patients may have lymphopenia.22, 23 Mild" exact="thrombocytopenia" post="is very common (but only rarely do platelet counts"/>
 <result pre="Some patients, especially the elderly, may have â€œsilent hypoxemiaâ€� and" exact="respiratory" post="failure without dyspnea.25 Approximately, 2% of patients may develop"/>
 <result pre="respiratory failure without dyspnea.25 Approximately, 2% of patients may develop" exact="pharyngitis" post="or tonsil enlargement.22 3 TRANSMISSION AND MANAGEMENT 3.1 Large"/>
 <result pre="3 TRANSMISSION AND MANAGEMENT 3.1 Large droplet transmission Typical of" exact="respiratory" post="viruses like influenza virus, SARSâ€�CoVâ€�2019 can spread through large"/>
 <result pre="restricted to ~6 ft from the patient).26 The droplet containing" exact="viral" post="particles (saliva or mucous droplets) can be ejected during"/>
 <result pre="There are currently no reports of intrauterine maternalâ€&quot;fetal transmission, but" exact="neonatal" post="transmission can occur.29 4 DRUGS TO TREAT COVIDâ€�19 Research"/>
 <result pre="trial Lopinavir/ritonavir Protease inhibitors, that work together to block the" exact="viral" post="replication 400â€‰mg/100â€‰mg, 2 times/d (Oral) Hypersensitivity reaction, Pancreatitis, Angioedema,"/>
 <result pre="together to block the viral replication 400â€‰mg/100â€‰mg, 2 times/d (Oral)" exact="Hypersensitivity" post="reaction, Pancreatitis, Angioedema, Toxic epidermal necrolysis, AV block, Renal"/>
 <result pre="viral replication 400â€‰mg/100â€‰mg, 2 times/d (Oral) Hypersensitivity reaction, Pancreatitis, Angioedema," exact="Toxic epidermal necrolysis," post="AV block, Renal failure Hyperglycaemia, Leukopenia, Hypertriglyceridemia, Neutropenia, Hepatotoxicity"/>
 <result pre="2 times/d (Oral) Hypersensitivity reaction, Pancreatitis, Angioedema, Toxic epidermal necrolysis," exact="AV block," post="Renal failure Hyperglycaemia, Leukopenia, Hypertriglyceridemia, Neutropenia, Hepatotoxicity etc. 11"/>
 <result pre="(Oral) Hypersensitivity reaction, Pancreatitis, Angioedema, Toxic epidermal necrolysis, AV block," exact="Renal" post="failure Hyperglycaemia, Leukopenia, Hypertriglyceridemia, Neutropenia, Hepatotoxicity etc. 11 trials"/>
 <result pre="11 trials (for instance NCT04307693, 3/13/20) Remdesivir Gets incorporated into" exact="viral" post="RNA leading to RNA termination trouble and inhibition of"/>
 <result pre="viral RNA leading to RNA termination trouble and inhibition of" exact="viral" post="replication. 200â€‰mg once for first day, followed by 100â€‰mg/d"/>
 <result pre="replication. 200â€‰mg once for first day, followed by 100â€‰mg/d (Intravenous)" exact="Elevated" post="liver enzymes, Nausea, Rectal bleeding, Vomiting etc. 6 trials"/>
 <result pre="by 600â€‰mg 2 times/d (Oral) Neurological and psychiatric symptoms, Anaphylaxis," exact="Hepatic" post="dysfunction, Acute kidney injury, Toxic Epidermal Necrolysis (TEN), Colitis"/>
 <result pre="2 times/d (Oral) Neurological and psychiatric symptoms, Anaphylaxis, Hepatic dysfunction," exact="Acute" post="kidney injury, Toxic Epidermal Necrolysis (TEN), Colitis haemorrhage etc."/>
 <result pre="times/d (Oral) Neurological and psychiatric symptoms, Anaphylaxis, Hepatic dysfunction, Acute" exact="kidney injury," post="Toxic Epidermal Necrolysis (TEN), Colitis haemorrhage etc. Atleast three"/>
 <result pre="Anaphylaxis, Hepatic dysfunction, Acute kidney injury, Toxic Epidermal Necrolysis (TEN)," exact="Colitis" post="haemorrhage etc. Atleast three trials (eg, NCT04303299 3/12/2020) Chloroquine"/>
 <result pre="times/d (Oral) Anaphylaxis or anaphylactoid reaction, Neuropsychiatric disorders, Neuromuscular impairment," exact="Hepatitis" post="thrombocytopenia, Pancytopenia, Neutropenia, aplastic anaemia etc. At least ten"/>
 <result pre="reaction, Neuropsychiatric disorders, Neuromuscular impairment, Hepatitis thrombocytopenia, Pancytopenia, Neutropenia, aplastic" exact="anaemia" post="etc. At least ten trials (eg, NCT04303507, 3/11/20; NCT04261517,"/>
 <result pre="3/11/20; NCT04261517, 2/14/20) Ribavirin Nucleoside analog of ribofuranose that inhibits" exact="viral" post="RNA synthesis 500â€‰mg for 2â€�3 times/d in combination with"/>
 <result pre="for 2â€�3 times/d in combination with lopinavir/ritonavir or IFNâ€�Î± (Intravenous)" exact="Cardiac" post="arrest, Pulmonary function deterioration, Headache, Fatigue, Abdominal cramps, Chronic"/>
 <result pre="times/d in combination with lopinavir/ritonavir or IFNâ€�Î± (Intravenous) Cardiac arrest," exact="Pulmonary" post="function deterioration, Headache, Fatigue, Abdominal cramps, Chronic obstructive lung"/>
 <result pre="(Intravenous) Cardiac arrest, Pulmonary function deterioration, Headache, Fatigue, Abdominal cramps," exact="Chronic" post="obstructive lung disease, Chest soreness, Ventilator dependence, Conjunctivitis etc."/>
 <result pre="Cardiac arrest, Pulmonary function deterioration, Headache, Fatigue, Abdominal cramps, Chronic" exact="obstructive lung disease," post="Chest soreness, Ventilator dependence, Conjunctivitis etc. At least 5"/>
 <result pre="arrest, Pulmonary function deterioration, Headache, Fatigue, Abdominal cramps, Chronic obstructive" exact="lung disease," post="Chest soreness, Ventilator dependence, Conjunctivitis etc. At least 5"/>
 <result pre="Abdominal cramps, Chronic obstructive lung disease, Chest soreness, Ventilator dependence," exact="Conjunctivitis" post="etc. At least 5 trials (NCT04254874, 2/5/20; ChiCTR2000029308, 1/23/20)"/>
 <result pre="Skin rashes, Pain etc. One trial (NCT04261270, 2/7/20) Arbidol Blocks" exact="viral" post="fusion 200â€‰mg for 3 times/d (Oral) Diarrhoea, Nausea, Dizziness,"/>
 <result pre="viral fusion 200â€‰mg for 3 times/d (Oral) Diarrhoea, Nausea, Dizziness," exact="Elevated" post="serum transaminase Two trials (NCT04260594,2/7/20; NCT04286503, 2/27/20) 4.1 Lopinavir/ritonavir"/>
 <result pre="ritonavir are protease inhibitors that work in conjunction to block" exact="viral" post="replication. Ritonavir, being a CYP3A inhibitor, reduces the metabolism"/>
 <result pre="is processed by the RNA polymerase and gets incorporated into" exact="viral" post="RNA. This leads to RNA termination and inhibition of"/>
 <result pre="viral RNA. This leads to RNA termination and inhibition of" exact="viral" post="replication. Five clinical trials of this drug are underway"/>
 <result pre="a component of several drug cocktail trials as patients with" exact="viral pneumonia" post="suffer more likely from influenza than from COVIDâ€�19.35 4.5"/>
 <result pre="component of several drug cocktail trials as patients with viral" exact="pneumonia" post="suffer more likely from influenza than from COVIDâ€�19.35 4.5"/>
 <result pre="A recent study reported that arbidol can efficiently inhibit SARSâ€�CoVâ€�2" exact="infection" post="in vitro at a concentration of 10 to 30â€‰Î¼M.34,"/>
 <result pre="10 to 30â€‰Î¼M.34, 36 4.6 Chloroquine Chloroquine, generally used for" exact="amebiasis" post="and malaria, is currently being considered for treating COVIDâ€�19"/>
 <result pre="taken. Invalid 5.2 Antigen detection test The presence of SARSâ€�CoVâ€�2" exact="viral" post="proteins (antigens) in a sample from the respiratory tract"/>
 <result pre="of SARSâ€�CoVâ€�2 viral proteins (antigens) in a sample from the" exact="respiratory" post="tract of a person can also be detected within"/>
 <result pre="the sample contains a sufficient concentration (actively replicating titre) of" exact="viral" post="proteins (target antigens), it will produce a visually detectable"/>
 <result pre="developing antibody response. Till then, the opportunities of disruption of" exact="disease" post="transmission and clinical interventions might have already passed. Also,"/>
 <result pre="the populations as susceptible (S), quarantined susceptible (Sq), exposed (E)," exact="infectious" post="and symptomatic (I), infectious but not yet symptomatic (preâ€�symptomatic)"/>
 <result pre="as susceptible (S), quarantined susceptible (Sq), exposed (E), infectious and" exact="symptomatic" post="(I), infectious but not yet symptomatic (preâ€�symptomatic) (A), hospitalized"/>
 <result pre="(S), quarantined susceptible (Sq), exposed (E), infectious and symptomatic (I)," exact="infectious" post="but not yet symptomatic (preâ€�symptomatic) (A), hospitalized (H), recovered"/>
 <result pre="exposed (E), infectious and symptomatic (I), infectious but not yet" exact="symptomatic" post="(preâ€�symptomatic) (A), hospitalized (H), recovered (R), and death (D)"/>
 <result pre="A conceptual SEIR model for COVIDâ€�19 Considering P as the" exact="total" post="population, it is assumed that the susceptible population (S)"/>
 <result pre="The exposed individuals can get infected and move either to" exact="infectious" post="and symptomatic (I) or infectious but not yet symptomatic/presymptomatic"/>
 <result pre="individuals can get infected and move either to infectious and" exact="symptomatic" post="(I) or infectious but not yet symptomatic/presymptomatic to (A)"/>
 <result pre="infected and move either to infectious and symptomatic (I) or" exact="infectious" post="but not yet symptomatic/presymptomatic to (A) compartment depending upon"/>
 <result pre="number of cases, and R0 = 1 indicates that the" exact="disease" post="is endemic. The key insights/highlights of these models are"/>
 <result pre="(R0) value was reduced by 25% and 50%, the estimated" exact="total" post="number of cumulative cases would be reduced from 1514"/>
 <result pre="governmental actions. The simulation results showed that the daily new" exact="infections" post="fell dramatically as the governmental actions and individual reactions"/>
 <result pre="as starting point to carry forward numerical simulations of the" exact="disease" post="spread to other countries. 10. Cleo Anastassopoulou, et al67"/>
 <result pre="in close estimates. 7 IMPACT OF COVIDâ€�19 ON WORLD ECONOMY" exact="Viral" post="spread has borne out experts' downside fears, with consequences"/>
 <result pre="seems to have decelerated in China, COVIDâ€�19 has gone global." exact="Infections" post="are escalating in Europe, United States, Iran, South Korea,"/>
 <result pre="encourage â€œsocial distancingâ€� and consumers stay indoors, the International Air" exact="Transport" post="Association has envisaged that COVIDâ€�19 possibly would cost global"/>
 <result pre="film market: This industry could lose over $5 billion in" exact="lower" post="box office sales. Hotel companies and restaurants: These have"/>
 <result pre="is duly acknowledged. References REFERENCES 1GorbalenyaAE, BakerSC, BaricRS, et al." exact="Severe" post="acute respiratory syndromeâ€�related coronavirus: the species and its virusesâ€�a"/>
 <result pre="duly acknowledged. References REFERENCES 1GorbalenyaAE, BakerSC, BaricRS, et al. Severe" exact="acute" post="respiratory syndromeâ€�related coronavirus: the species and its virusesâ€�a statement"/>
 <result pre="acknowledged. References REFERENCES 1GorbalenyaAE, BakerSC, BaricRS, et al. Severe acute" exact="respiratory" post="syndromeâ€�related coronavirus: the species and its virusesâ€�a statement of"/>
 <result pre="2collab: WHO . 2020https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-mediabriefing-on-2019-ncov-on-11-february-2020 3ChanJF, YuanS, KokKH, et al. A" exact="familial" post="cluster of pneumonia associated with the 2019 novel coronavirus"/>
 <result pre="2020https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-mediabriefing-on-2019-ncov-on-11-february-2020 3ChanJF, YuanS, KokKH, et al. A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating personâ€�toâ€�person transmission:"/>
 <result pre="Engl J Med. 2020;382:1199â€�1207. 10.1056/NEJMoa2001316.31995857 5LaiCC, ShihTP, KoWC, TangHJ, HsuehPR." exact="Severe" post="acute respiratory syndrome coronavirus 2 (SARSâ€�CoVâ€�2) and corona virus"/>
 <result pre="J Med. 2020;382:1199â€�1207. 10.1056/NEJMoa2001316.31995857 5LaiCC, ShihTP, KoWC, TangHJ, HsuehPR. Severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARSâ€�CoVâ€�2) and corona virus diseaseâ€�2019"/>
 <result pre="Med. 2020;382:1199â€�1207. 10.1056/NEJMoa2001316.31995857 5LaiCC, ShihTP, KoWC, TangHJ, HsuehPR. Severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARSâ€�CoVâ€�2) and corona virus diseaseâ€�2019 (COVIDâ€�19):"/>
 <result pre="2020;382:1199â€�1207. 10.1056/NEJMoa2001316.31995857 5LaiCC, ShihTP, KoWC, TangHJ, HsuehPR. Severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARSâ€�CoVâ€�2) and corona virus diseaseâ€�2019 (COVIDâ€�19): the"/>
 <result pre="Novel Coronavirus (nCoV). https://nextstrain.org/groups/blab/sars-like-cov 11ZhouP, YangXL, WangXG, et al. A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
 <result pre="ShiL, WangY, et al. Pathological findings of COVIDâ€�19 associated with" exact="acute" post="respiratory distress syndrome. Lancet Respir Med. 2020;8:420â€�422. 10.1016/S2213-2600(20)30076-X.32085846 19RuanQ,"/>
 <result pre="WangY, et al. Pathological findings of COVIDâ€�19 associated with acute" exact="respiratory" post="distress syndrome. Lancet Respir Med. 2020;8:420â€�422. 10.1016/S2213-2600(20)30076-X.32085846 19RuanQ, YangK,"/>
 <result pre="in Singapore. JAMA. 2020;3. 21ChanJF, YuanS, KokKH, et al. A" exact="familial" post="cluster of pneumonia associated with the 2019 novel coronavirus"/>
 <result pre="2020;3. 21ChanJF, YuanS, KokKH, et al. A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating personâ€�toâ€�person transmission:"/>
 <result pre="2020;S0140â€�6736(20):30154â€�30159. 22GuanWJ, NiZY, HuY, et al. Clinical characteristics of coronavirus" exact="disease" post="2019 in China. N Engl J Med. 2020;382:1708â€�1720. 10.1056/NEJMoa2002032.32109013"/>
 <result pre="Clinical course and outcomes of critically ill patients with SARSâ€�CoVâ€�2" exact="pneumonia" post="in Wuhan, China: a singleâ€�centered, retrospective, observational study. Lancet"/>
 <result pre="Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirusâ€�Infected" exact="Pneumonia" post="in Wuhan, China. JAMA. 2020;323(11):1061â€�1069. 25XieJ, TongZ, GuanX, DuB,"/>
 <result pre="disinfection. J Hosp Infect. 2018;98(4):331â€�338.28882643 29PeyronnetV, SibiudeJ, DeruelleP, et al." exact="Infection" post="with SARSâ€�CoVâ€�2 in pregnancy. Information and proposed care. CNGOF."/>
 <result pre="2020;11(1):222 1â€&quot;4.31924756 34DongL, HuS, GaoJ. Discovering drugs to treat coronavirus" exact="disease" post="2019 (COVIDâ€�19). Drug Discov Ther. 2020;14(1):58â€�60.32147628 35AdaljaAA. Oseltamivir protective"/>
 <result pre="analogs as a promising strategy for the treatment of emerging" exact="viral" post="diseases. Pharmacol Res Perspect. 2017;5(1). 40ColsonP, RolainJM, RaoultD. Chloroquine"/>
 <result pre="Antimicrob Agents. 2020;20:105949. 43SahraeiZ, ShabaniM, ShokouhiS, SaffaeiA. Aminoquinolines Against Coronavirus" exact="Disease" post="2019 (COVIDâ€�19): Chloroquine or Hydroxychloroquine. Int J Antimicrob Agents."/>
 <result pre="WhiteJM, FriemanMB. Abelson kinase inhibitors are potent inhibitors of severe" exact="acute" post="respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus"/>
 <result pre="FriemanMB. Abelson kinase inhibitors are potent inhibitors of severe acute" exact="respiratory" post="syndrome coronavirus and Middle East respiratory syndrome coronavirus fusion."/>
 <result pre="Abelson kinase inhibitors are potent inhibitors of severe acute respiratory" exact="syndrome" post="coronavirus and Middle East respiratory syndrome coronavirus fusion. J"/>
 <result pre="inhibitors of severe acute respiratory syndrome coronavirus and Middle East" exact="respiratory" post="syndrome coronavirus fusion. J Virol. 2016;90:8924â€�8933.27466418 46Shanghai Institute of"/>
 <result pre="of severe acute respiratory syndrome coronavirus and Middle East respiratory" exact="syndrome" post="coronavirus fusion. J Virol. 2016;90:8924â€�8933.27466418 46Shanghai Institute of Materia"/>
 <result pre="https://www.fda.gov/media 48BruningAHL, LeeflangMMG, VosJMBW, et al. Rapid tests for influenza," exact="respiratory" post="syncytial virus, and other respiratory viruses: a systematic review"/>
 <result pre="al. Rapid tests for influenza, respiratory syncytial virus, and other" exact="respiratory" post="viruses: a systematic review and metaâ€�analysis. Clin Infect Dis."/>
 <result pre="recombinant nucleocapsid and spice protein serological diagnosis of novel coronavirus" exact="disease" post="2019 (COVIDâ€�19). medxriv. 202010.1101/2020.03.17.20036954v1. 52PanY, LiX, et al. Serological"/>
 <result pre="application of a rapid IgMâ€�IgG combined antibody test for SARSâ€�CoVâ€�2" exact="infection" post="diagnosis. J Med Virol. 10.1002/jmv.25727. 54ChenT, RuiJ, WangQ, ZhaoZ,"/>
 <result pre="Donnelly, C., Riley, S., Ferguson, N.M.Report 2: estimating the potential" exact="Total" post="number of novel coronavirus cases in Wuhan City, Chinahttps://www.preventionweb.net/news/view/70092"/>
 <result pre="10.1186/s40249-020-00640-3.31996251 64Jomar F.Rabajante. Insights from early mathematical models of 2019â€�nCoV" exact="acute" post="respiratory disease (COVIDâ€�19) dynamics, 2020https://arxiv.org/abs/2002.05296 65ZhouT, LiuQ, YangZ, et"/>
 <result pre="64Jomar F.Rabajante. Insights from early mathematical models of 2019â€�nCoV acute" exact="respiratory" post="disease (COVIDâ€�19) dynamics, 2020https://arxiv.org/abs/2002.05296 65ZhouT, LiuQ, YangZ, et al."/>
 <result pre="F.Rabajante. Insights from early mathematical models of 2019â€�nCoV acute respiratory" exact="disease" post="(COVIDâ€�19) dynamics, 2020https://arxiv.org/abs/2002.05296 65ZhouT, LiuQ, YangZ, et al. Preliminary"/>
 <result pre="ZhaoS, GaoD, et al. A conceptual model for the coronavirus" exact="disease" post="2019 (COVIDâ€�19) outbreak in Wuhan, China with individual reaction"/>
</results>
